Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  NIDA research monograph

• Publication date

  1998-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 9686407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.

  1994cited by this paper
• Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.

  1992cited by this paper
• Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study.

  1990cited by this paper
• Cocaine receptors on monoamine transporters and sodium channels.

  1988cited by this paper
• Cocaine receptors on dopamine transporters mediate cocaine-reinforced behavior.

  1988cited by this paper
• Noradrenergic component in the vasoconstriction induced by 5‐hydroxytryptamine in goat cerebral arteries

  1981cited by this paper
• Differential behaviour of LPH‐(61–91)‐peptide in different model systems: Comparison of the opioid activities of LPH‐(61–91)‐peptide and its fragments

  1977cited by this paper
• EFFECT OF MORPHINE ON ADRENERGIC TRANSMISSION IN THE MOUSE VAS DEFERENS. ASSESSMENT OF AGONIST AND ANTAGONIST POTENCIES OF NARCOTIC ANALGESICS

  1975cited by this paper
• A protein binding assay for adenosine 3':5'-cyclic monophosphate.

  1970cited by this paper
• The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea‐pig ileum longitudinal muscle strip

  1969cited by this paper
• Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).

  1968cited by this paper
• pAx and competitive drug antagonism.

  1949cited by this paper

• Divergence in μ and δ opioid receptor pharmacology in neurons and antinociceptive efficacy in neuropathic pain: Insights from MP135 and CYM51010.

  2026cites this paper
• Role of Serotonin in the Neurobiology of Schizophrenia and Association With Negative Symptoms.

  2025cites this paper
• Use of Multiple Naloxone Administrations in the Emergency Department: A Retrospective Claims-Based Analysis.

  2025cites this paper
• Assessment of μ-Opioid Receptor Signaling Responses for Fentanyl Analogs Using Luciferase Complementation Assay.

  2025cites this paper
• Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits

  2025influential citation
• Targeted inhibition of mu-opioid receptors in neuronal subpopulations by membrane-tethered Naloxo-DART antagonists.

  2025cites this paper
• Opioid receptors in GtoPdb v.2025.1

  2025cites this paper
• Opioid receptors in GtoPdb v.2025.3

  2025cites this paper
• Kappa opioid receptor control of motivated behavior revisited

  2025cites this paper
• In Silico Evaluation of the Effect of Geometrical Configuration and Charge of Opioid Antagonists on Their Binding to Receptors

  2025cites this paper
• Advances in animal models of prenatal opioid exposure.

  2024cites this paper
• Time Course of Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone

  2024cites this paper
• High-throughput label-free opioid receptor binding assays using an automated desorption electrospray ionization mass spectrometry platform

  2024cites this paper
• Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest

  2024cites this paper
• Unlocking opioid neuropeptide dynamics with genetically encoded biosensors

  2024cites this paper
• Structure-Activity Relationships of the Fentanyl Scaffold: Identification of Antagonists as Potential Opioid Overdose Reversal Agents.

  2024cites this paper
• Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the μ-opioid receptor

  2024influential citation
• Synthetic opioids have disrupted conventional wisdom for treating opioid overdose

  2024cites this paper
• Pharmacologic Characterization of Substituted Nitazenes at μ, κ, and Δ Opioid Receptors Suggests High Potential for Toxicity

  2024cites this paper
• Descriptive molecular pharmacology of the δ opioid receptor (DOR): A computational study with structural approach

  2024cites this paper
• Precision Medicine in Antidepressants Treatment.

  2023cites this paper
• Opioid receptors in GtoPdb v.2023.1 Opioid receptors in GtoPdb v.2023.1

  2023cites this paper
• Structure, function and drug discovery of GPCR signaling

  2023cites this paper
• Structural basis of efficacy-driven ligand selectivity at GPCRs

  2023cites this paper
• Fixed Dose Versus Loose Dose: Analgesic Combinations

  2023cites this paper
• An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine

  2023cites this paper
• 6‐Nitrodopamine is an endogenous mediator of the rabbit corpus cavernosum relaxation

  2023cites this paper
• A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia

  2023cites this paper
• Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.

  2023cites this paper
• Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview

  2023cites this paper
• A Novel Multi-Target Mu/Delta Opioid Receptor Agonist, HAGD, Produced Potent Peripheral Antinociception with Limited Side Effects in Mice and Minimal Impact on Human Sperm Motility In Vitro

  2023cites this paper
• Neuropeptide System Regulation of Prefrontal Cortex Circuitry: Implications for Neuropsychiatric Disorders

  2022cites this paper
• Opioidergic Signaling—A Neglected, Yet Potentially Important Player in Atopic Dermatitis

  2022cites this paper
• Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade

  2022cites this paper
• Interaction With the Lipid Membrane Influences Fentanyl Pharmacology

  2022cites this paper
• The Role of the Endogenous Opioid System in the Vocal Behavior of Songbirds and Its Possible Role in Vocal Learning

  2022cites this paper
• The role of endogenous opioid neuropeptides in neurostimulation-driven analgesia

  2022cites this paper
• Metadynamics simulations leveraged by statistical analyses and artificial intelligence-based tools to inform the discovery of G protein-coupled receptor ligands

  2022cites this paper
• A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse.

  2022cites this paper
• Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose

  2022cites this paper
• Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge.

  2022cites this paper
• Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor

  2022cites this paper
• Hepatic and renal toxicities and metabolism of fentanyl analogues in rats

  2022cites this paper
• "Selective" serotonin 5-HT2A receptor antagonists.

  2022cites this paper
• Fentanyl binds to the μ-opioid receptor via the lipid membrane and transmembrane helices

  2021influential citation
• Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators.

  2021cites this paper
• The Biological Activity of Designer Drugs from the Group of Synthetic Opioids

  2021influential citation
• Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons

  2021cites this paper
• Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users

  2021cites this paper
• Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent

  2021cites this paper
• Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids

  2021cites this paper
• Pharmacological Diversity in Opioid Analgesics: Lessons From Clinically Useful Drugs

  2021cites this paper
• Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols

  2021cites this paper
• Construction of a Virtual Opioid Bioprofile: A Data-Driven QSAR Modeling Study to Identify New Analgesic Opioids.

  2021cites this paper
• Treatment of overdose in the synthetic opioid era.

  2021influential citation
• L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter.

  2021cites this paper
• Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities

  2021cites this paper
• In vivo photopharmacology with a caged mu opioid receptor agonist drives rapid changes in behavior

  2021cites this paper
• In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile.

  2020cites this paper
• Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.

  2020cites this paper
• The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach.

  2020cites this paper
• In vitro Pharmacology of Fentanyl Analogs at the Human Mu Opioid Receptor and Their Spectroscopic Analysis.

  2020cites this paper
• Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level

  2020cites this paper
• An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Receptor Modulator Buprenorphine

  2020cites this paper
• Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block

  2020cites this paper
• Case Report: Buprenorphine-A Treatment for Psychological Pain and Suicidal Ideation?

  2020cites this paper
• Hyporesponsivity to mu-opioid receptor agonism in the Wistar-Kyoto rat model of altered nociceptive responding associated with negative affective state.

  2020cites this paper
• A Critical Examination of the Mechanism of Action of Buprenorphine: Not Just a Mu Partial Agonist?

  2020cites this paper
• Thienorphine induces antinociception without dependence through activation of κ- and δ-, and partial activation of μ- opioid receptor.

  2020cites this paper
• Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats

  2020cites this paper
• Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse

  2020cites this paper
• Advances in Understanding the Initial Steps of Pruritoceptive Itch: How the Itch Hits the Switch

  2020cites this paper
• The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.

  2019cites this paper
• Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge

  2019cites this paper
• Biased agonism as an emerging strategy in the search for better opioid analgesics.

  2019cites this paper
• Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial.

  2019cites this paper
• Structure–Activity Relationships of 7-Substituted Dimethyltyrosine-Tetrahydroisoquinoline Opioid Peptidomimetics

  2019cites this paper
• Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats

  2019cites this paper
• Special Section on The Opioid Crisis Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose

  2019cites this paper
• Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands

  2019cites this paper
• Structure and dynamics of dynorphin peptide and its receptor.

  2019cites this paper
• Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimer

  2019cites this paper
• Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective

  2019cites this paper
• Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose

  2019cites this paper
• Fentanyl depression of respiration: comparison with heroin and morphine

  2019cites this paper
• Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia

  2018cites this paper
• 5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

  2018cites this paper
• In vitro and in silico analysis of the effects of D 2 receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations

  2018cites this paper
• Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile

  2018cites this paper
• Luciferase complementation based-detection of G-protein-coupled receptor activity.

  2018cites this paper
• Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

  2018cites this paper
• PET Imaging of the 5-HT 2A Receptor System: A Tool to Study the Receptor’s In Vivo Brain Function

  2018cites this paper
• The β‐adrenoceptor blocker propranolol ameliorates compulsive‐like gambling behaviour in a rodent slot machine task: implications for iatrogenic gambling disorder

  2018cites this paper
• In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential

  2017influential citation
• Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors

  2017cites this paper
• Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships

  2017cites this paper
• The Effects of Naltrexone on Neural Responses to Methamphetamine Cues

  2017cites this paper
• Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities.

  2017cites this paper
• Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice

  2017cites this paper